Dr. Mark Trampe

BS ChE ’84, Missouri University of Science & Technology

MS ChE ’87, University of Illinois

PhD ChE ’89, University of Illinois

Mark Trampe graduated from the Missouri University of Science and Technology in 1984 with a B.S. degree in Chemical Engineering. He went on to graduate school from the University of Illinois with a Masters in Chemical Engineering in 1987, and a Doctorate in Chemical Engineering in 1989.

Mark began his career at Union Carbide (now Dow). Over the course of nineteen years, he conducted process research for several specialty chemicals businesses. His research focused on scale-up of new products and development of process optimization concepts, which were followed by tech transfer to commercial-scale manufacturing sites. He was awarded a Dow Technology Award for improvements to the methyl cellulose process. Mark has one process patent for an electrodialytic process to convert waste sodium acetate back to virgin sodium hydroxide and acetic acid for recycle. He also implemented process analytical technologies at multiple manufacturing sites for improved process control and production capacity improvement.

Mark then accepted a position at FMC at their Innovation Center, involved in process development of new formulation technologies for agricultural products. He was responsible for the tech transfer of two new fungicide product lines to multiple global sites. He then moved into the pharmaceutical arena by accepting a position with Johnson Matthey Pharmaceutical Materials (now Veranova).

Mark is the technical leader for the commercial manufacturing of new drug products. As a contract manufacturer, Veranova provides manufacturing capabilities for novel therapeutic treatments developed by their customers. Mark’s initial project was the start-up of commercial manufacture of the drug eteplirson which combats Duchenne muscular dystrophy. Subsequent projects involved drugs for pain management, ADHD, and cancer. It’s been a rewarding way to finish a career knowing the impact these drugs have on patient quality of life. Mark is married (Diane) with three adult children and enjoys travel and following his favorite sports teams. He currently lives in Hillsborough, New Jersey.